Artios Presents Positive Initial Phase 1/1b Clinical Monotherapy Data for ATR Inhibitor ART0380 in Advanced Solid Tumors at the European Society of Medical Oncology Congress 2023 23 October 2023 | Press release
Artios to Present Initial Phase 1 Clinical Monotherapy Data for ATR Inhibitor ART0380 in Advanced Solid Tumors at the European Society of Medical Oncology Congress 2023 5 October 2023 | Press release
Professor Sir Stephen Jackson receives a knighthood for services to innovation and research 19 June 2023 | Announcement
IUCT-Oncopole & Artios join forces to overcome resistance to therapies for familial breast cancer 13 April 2023 | Press release
EACR-AACR Immune Response and DNA Repair Cancer Fields Converging Conference 23 March 2023 | Conferences
Artios Announces Initiation of Phase 2 Randomized Trial for ATR Inhibitor ART0380 plus Gemcitabine in Patients with Platinum Resistant Ovarian Cancer 9 February 2023 | Press release
Artios initiates Phase 2 study of Polθ Inhibitor ART4215 in Combination with PARP Inhibitor Talazoparib in BRCA Deficient Breast Cancer 10 August 2022 | Press release